abrdn Life Sciences Investors Shares of Beneficial Interest financial statements, including revenue, expenses, profit, and loss

The total revenue of HQL for the last semiannual is -225.19 k USD, and it's 100.76% lower compared to the previous semiannual. The net income of H1 24 is 50.26 M USD.